(Q53659697)
Statements
A cost-benefit comparison of intensive diabetes management with implantable pumps versus multiple subcutaneous injections in patients with type I diabetes. (English)
Haardt MJ
Selam JL
Slama G
Bethoux JP
Dorange C
Mace B
Ramaniche ML
Bruzzo F
1 August 1994
17
8
847-851